MEETINGS - Meeting on the New US Legislation on Drugs and Medical Devices (UK) January 1998:
This article was originally published in Clinica
Executive Summary
Management Forum will hold a meeting on the New US Legislation on Drugs and Medical Devices in London on January 19. There will be a full report on the new rules affecting the pharmaceutical and medical device industries and other discussion topics include changes in the way the FDA does business with industry; new requirements for most product sectors regulated by the agency; and the practical effects the new rules will have on approval times for drugs and devices. For more information contact Management Forum in the UK. Tel: +44 1483 570 099. Fax: +44 1483 536424..
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.